Science ❯ Biotechnology ❯ Vaccine Development

Clinical Trials

H5N1 Vaccine mRNA Vaccine Trials Phase II Trials Regulatory Affairs mRNA Vaccines Safety Protocols mRNA Therapies Immunology mRNA Technology Safety Concerns Research Studies Phase 1 Trials

Membrane-Bound mRNA HIV Vaccine Elicits Neutralizing Antibodies in 80% of Participants

An unexpected rate of hives in participants has prompted vaccine tweaks ahead of larger trials.